Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Other Non-Current Liabilities (2010 - 2026)

Omnicell's (OMCL) quarterly Other Non-Current Liabilities came in at $11.1 million in Q2 2026, up 39.82% year-over-year from $8.0 million in Q2 2025, and up 9.64% quarter-over-quarter from $10.2 million in Q1 2026.

Analysis

Omnicell (OMCL) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Other Non-Current Liabilities for 17 consecutive years, with $11.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 39.82% year-over-year to $11.1 million in Q2 2026; TTM through Jun 2026 was $11.1 million, a 39.82% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 38.13% from the prior year.
  • Other Non-Current Liabilities was $11.1 million for Q2 2026 at Omnicell, up from $10.2 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $11.1 million in Q2 2026 and troughed at $6.1 million in Q1 2023.
  • A 5-year average of $7.9 million and a median of $7.5 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities slumped 60.35% in 2022 and soared 39.82% in 2026, its largest moves.
  • Over 5 years, Other Non-Current Liabilities stood at $6.7 million in 2022, then decreased by 5.97% to $6.3 million in 2023, then gained by 14.25% to $7.2 million in 2024, then soared by 38.13% to $10.0 million in 2025, then gained by 11.79% to $11.1 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $11.1 million (Q2 2026), $10.2 million (Q1 2026), and $10.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.15 Mn
Mar 31, 2026 10.17 Mn
Dec 31, 2025 9.97 Mn
Sep 30, 2025 8.23 Mn
Jun 30, 2025 7.97 Mn
Mar 31, 2025 7.58 Mn
Dec 31, 2024 7.22 Mn
Sep 30, 2024 8.00 Mn
Jun 30, 2024 7.51 Mn
Mar 31, 2024 7.10 Mn
Dec 31, 2023 6.32 Mn
Sep 30, 2023 6.43 Mn
Jun 30, 2023 6.27 Mn
Mar 31, 2023 6.14 Mn
Dec 31, 2022 6.72 Mn
Sep 30, 2022 9.29 Mn
Jun 30, 2022 8.81 Mn
Mar 31, 2022 7.35 Mn
Dec 31, 2021 7.84 Mn
Sep 30, 2021 10.76 Mn